Abstract:The Wnt/β-catenin pathway is constitutively active and promotes multiple tumor processes, including breast cancer metastasis. However, the underlying mechanism by which the Wnt/β-catenin pathway is constitutively activated in breast cancer metastasis remains unclear. Inhibition of Wnt antagonists is important for Wnt/β-catenin signaling activation, and post-transcriptional regulation of these antagonists by microRNAs (miRNAs) might be a possible mechanism underlying signaling activation. Regulation of nuclear pre-mRNA domain-containing 1A (RPRD1A) is a known inhibitor of cell growth and Wnt/β-catenin signaling activity, but the function and regulatory mechanism of RPRD1A in breast cancer have not been clarified. The aim of this study was to understand how regulators of the Wnt/β-catenin pathway may play a role in the metastasis of this cancer. Methods: RPRD1A expression and its association with multiple clinicopathological characteristics was analyzed immunohistochemically in human breast cancer specimens. miR-454-3p expression was analyzed using real-time PCR. RPRD1A or miR-454-3p knockdown and overexpression were used to determine the underlying mechanism of their functions in breast cancer cells. Xenografted tumor model, 3D invasive culture, cell migration and invasion assays and sphere formation assay were used to determine the biofunction of RPRD1A and miR-454-3p in breast cancer. Electrophoretic mobility shift assay (EMSA), luciferase reporter assay, and RNA immunoprecipitation (RIP) were performed to study the regulation and underlying mechanisms of RPRD1A and miR-454-3p expression and their correlation with the Wnt/β-catenin pathway in breast cancer. Results: The Wnt/β-catenin signaling antagonist RPRD1A was downregulated and its upstream regulator miR-454-3p was amplified and overexpressed in metastatic breast cancer, and both were correlated with overall and relapse-free survival in breast cancer patients. The suppression by miR-454-3p on RPRD1A was found to activate Wnt/β-catenin signaling, thereby promoting metastasis. Simultaneously, three other negative regulators of the Wnt/β-catenin pathway, namely, AXIN2, dickkopf WNT signaling pathway inhibitor (DKK) 3 and secreted frizzled related protein (SFRP) 1, were also found to be targets of miR-454-3p and were involved in the signaling activation. miR-454-3p was found to be involved in early metastatic processes and to promote the stemness of breast cancer cells and early relapse under both in vitro and in vivo conditions. Conclusions: The findings indicate that miR-454-3p-mediated suppression of Wnt/β-catenin antagonist RPRD1A, as well as AXIN2, DKK3 and SFRP1, sustains the constitutive activation of Wnt/β-catenin signaling; thus, miR-454-3p and RPRD1A might be potential diagnostic and therapeutic targets for breast cancer metastasis.

Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation

Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

Stabilization of the transcription factors slug and twist by the deubiquitinase dub3 is a key requirement for tumor metastasis.

CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1

Deubiquitinating Enzyme USP9X Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer by Stabilizing Snail1.

Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phosphatase SCP1 to stabilize Snail protein

MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells.

Inhibition of Migration and Invasion of Gastric Cancer Cells by Snail-Regulated Mir-375 Through Jak2 Targeting

USP37 Promotes Lung Cancer Cell Migration by Stabilizing Snail Protein Via Deubiquitination

A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.

Interaction with Suv39h1 is Critical for Snail-Mediated E-Cadherin Repression in Breast Cancer

Snail Contributes To The Maintenance Of Stem Cell-Like Phenotype Cells In Human Pancreatic Cancer

Snail and Slug Collaborate on Emt and Tumor Metastasis Through Mir-101-Mediated Ezh2 Axis in Oral Tongue Squamous Cell Carcinoma

MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis

Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.

Abstract 966: Snail Mediated Transcriptional Repression and EMT Requires Zinc-Finger and SNAG Domain Directed Phosphorylation: Identification of the Kinases and Evaluation As Therapeutic Targets

Dual Regulation of Snail by GSK-3β-mediated Phosphorylation in Control of Epithelial–mesenchymal Transition

SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis

SNAIL1: Linking Tumor Metastasis to Immune Evasion

P3.02-072 MiR-33b Inhibits Lung Adenocarcinoma Cell Epithelial-Mesenchymal Transition Through CeRNA Regulatory Network